Suven Life Sciences Ltd. | Small-cap | Healthcare
₹253.68
3.06%
| Suven Life Sciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 66.6M
Gross Profit 66.6M 100.00%
Operating Income -1.7B -2,578.13%
Net Income -1.6B -2,415.11%
EPS (Diluted) -₹7.37

Balance Sheet Metrics

Total Assets 1.4B
Total Liabilities 252.0M
Shareholders Equity 1.1B
Debt to Equity 0.23

Cash Flow Metrics

Operating Cash Flow -1.6B
Free Cash Flow -1.9B

Revenue & Profitability Trend

Suven Life Sciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 66.6M 116.9M 135.4M 118.4M 134.8M
Cost of Goods Sold 0 7.2M 3.7M 1.6M 328.0K
Gross Profit 66.6M 109.8M 131.7M 116.8M 134.5M
Research & Development 1.4B 1.1B 1.2B 1.1B 710.3M
Selling, General & Administrative - 27.1M 27.8M 24.9M 21.8M
Other Operating Expenses 342.9M 281.3M 269.6M 289.0M 233.9M
Total Operating Expenses 1.8B 1.5B 1.5B 1.4B 966.0M
Operating Income -1.7B -1.3B -1.3B -1.3B -831.6M
Pre-tax Income -1.6B -1.1B -1.2B -1.2B -774.7M
Income Tax 0 -10.0M 0 0 -53.2M
Net Income -1.6B -1.1B -1.2B -1.2B -721.5M
EPS (Diluted) -₹7.37 -₹4.82 -₹6.63 -₹9.05 -₹5.22

Income Statement Trend

Suven Life Sciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 754.7M 2.6B 2.5B 665.9M 1.0B
Non-Current Assets 597.1M 282.3M 1.4B 414.4M 257.4M
Total Assets 1.4B 2.8B 3.9B 1.1B 1.3B
Liabilities
Current Liabilities 234.9M 135.2M 111.3M 83.1M 159.1M
Non-Current Liabilities 17.1M 13.5M 24.6M 35.7M 45.0M
Total Liabilities 252.0M 148.6M 135.9M 118.9M 204.1M
Equity
Total Shareholders Equity 1.1B 2.7B 3.8B 961.5M 1.1B

Balance Sheet Composition

Suven Life Sciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income -1.6B -1.1B -1.2B -1.2B -774.7M
Operating Cash Flow -1.6B -1.2B -1.2B -1.3B -951.4M
Investing Activities
Capital Expenditures -372.8M 24.2M -28.9M -197.7M -63.0M
Investing Cash Flow -378.0M 4.9M -2.5B -233.5M 488.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow - 0 4.0B 1.5B 369.2M
Free Cash Flow -1.9B -1.2B -1.2B -1.5B -1.0B

Cash Flow Trend

Suven Life Sciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -32.18
Forward P/E 11.65
Price to Book 25.58
Price to Sales 648.90
PEG Ratio 11.65

Profitability Ratios

Profit Margin 100.00%
Operating Margin -3,078.90%
Return on Equity -146.15%
Return on Assets -118.91%

Financial Health

Current Ratio 3.21
Debt to Equity 0.00
Beta 0.82

Per Share Data

EPS (TTM) -₹7.36
Book Value per Share ₹8.81
Revenue per Share ₹0.35

Financial data is updated regularly. All figures are in the company's reporting currency.